You Position: Home > Paper
垂体腺瘤患者围手术期应用糖皮质激素的探讨
( views:258, downloads:173 )
- Author:
- No author available
- Journal Title:
- Chinese Journal of Neurosurgery
- Issue:
- 10
- DOI:
- 10.3760/cma.j.issn.1001-2346.2017.10.024
- Key Word:
- No keyword available
Abstract： 长期以来,学术界普遍认为,无论其垂体功能如何,垂体腺瘤患者围手术期应使用应激剂量的糖皮质激素进行替代治疗,以满足手术应激的需要[1].近年来,随着显微手术的发展与手术技术的提高,进行垂体腺瘤切除手术时对正常垂体的损伤越来越小,术后患者的垂体功能大多能够保留,对于垂体腺瘤患者围手术期激素减量或选择性使用的报道日益增加,减少或谨慎使用激素的安全性得到初步验证[2-3].西南医科大学附属医院神经外科自2010年以来逐步减少垂体腺瘤患者围手术期糖皮质激素的使用,现对2007年1月至2014年12月收治的121例垂体腺瘤患者的临床资料进行分析并报道如下.
- [1]何文强,马增翼,叶红英,等.经蝶窦垂体腺瘤切除术围手术期糖皮质激素替代必要性的研究[J].2015,(11).
- [2]中国垂体腺瘤协作组.中国垂体腺瘤外科治疗专家共识[J].2015,(5).
- [3]Jacqueline, Regan,Joseph, Watson.Selective use of peri-operative steroids in pituitary tumor surgery: escape from dogma.[J].2013,4.
- [4]Hunt PJ.Glucocorticoid Replacement in Pituitary Surgery: Guidelines for Perioperative Assessment and Management.[J].2002,87(6).
- [5]Mamatemin, Tohti,Junyang, Li,Yuan, Zhou,etc.Is peri-operative steroid replacement therapy necessary for the pituitary adenomas treated with surgery? A systematic review and meta analysis.[J].2015,10(3).
- [6]Thomas, Zueger,Paul, Kirchner,Coline, Herren,etc.Glucocorticoid replacement and mortality in patients with nonfunctioning pituitary adenoma.[J].2012,97(10).
- [7]Pereira O,Bevan JS.Preoperative assessment for pituitary surgery.[J].2008,11(4).
- [8]McLaughlin,N.,Cohan,P.,Barnett,P.,etc.Early morning cortisol levels as predictors of short-term and long-term adrenal function after endonasal transsphenoidal surgery for pituitary adenomas and rathke's cleft cysts[J].2013,80(5).
- [9]Cusimano,M.D.,Goguen,J.,DeTommasi,C..Transphenoidal surgery without steroid replacement in patients with morning serum cortisol below 9 μg/dl (250 Nmol/l)[J].2012,154(10).
- [10]Bhansali A,Dutta P,Bhat MH,etc.Rational use of glucocorticoid during pituitary surgery - A pilot study.[J].2008,128(3).
- [11]Arlt W,Allolio B.Adrenal insufficiency.[J].2003,361(9372).
- [12]R A, Kristof,M, Wichers,D, Haun,etc.Peri-operative glucocorticoid replacement therapy in transsphenoidal pituitary adenoma surgery: a prospective controlled study.[J].2008,150(4).